跳至主要内容
临床试验/NCT04005456
NCT04005456已完成不适用

LIFE-HOUSE: A Lifestyle Intervention and Functional Evaluation - a Health Outcomes Survey

Metagenics, Inc.1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2018年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
400
试验地点
1
主要终点
University of Rhode Island Change Assessment (URICA) questionnaire

研究概览

简要总结

The LIFE-HOUSE research project is designed to evaluate the impact of a personalized lifestyle intervention program on functional capacity as an approach to quantitating health, and its relationship to well understood disease risk determinants.

LIFE-HOUSE will utilize an innovative Tent-Umbrella-Bucket design.

Participants will gather under the Tent of an all-inclusive 'N of 1' Case Series providing a shelter of Functional Medicine interventions against the storm of chronic disease. Under this Tent are a collection of Umbrellas where participants with similar clinical challenges are evaluated as clinically defined groups with loose guidelines for the planned interventions. Finally, participants standing under these Umbrellas may step into specific Buckets that gather individuals with nearly identical clinical presentations into more formally described prescriptive randomized arms for intervention.

Individuals will be offered the opportunity to participate in all Umbrellas and Buckets for which they qualify. They may accept or reject participation in any Umbrella or Bucket and yet remain eligible for participation in the overall Tent.

详细描述

It has been suggested that the best medicine should value four principles (4P) - medicine should be personalized, predictive, preventative and participatory. This 4P Medicine will thus be personalized and patient centered with a focus on the person who has the disease and not the disease the person has. It will be predictive as it identifies the pre-clinical trend/decline towards illness sooner than onset of symptoms that herald the loss of function and health. It will be preventative as the information gathered should offer opportunities to modify these trajectories towards illness and finally it will be participatory as individuals will be intimately involved in the gathering of data to identify trends and in the application of lifestyle measures to improve their lives.

There is a significant unmet need to identify the value of a personalized lifestyle intervention program for improving functional health outcomes. Whereas disease is well understood from traditional pathology-based indices, health is less easily defined. Historically, healthy has been the default term that is applied to an individual who is not recognized as having a disease. This definition of health as the absence of disease has resulted in the delivery of health and wellness as often lying outside the purview of medicine.

An evolving definition of health, however, is to recognize that it is related to the functional capacity of the individual. Functional capacity can be categorized in four assessment areas: physiological, physical, cognitive and emotional. All four of these subcategories are quantifiable by both qualitative and quantitative metrics. The effects on health of a multi-modal personalized lifestyle medicine intervention program can best be evaluated by using functional determinants.

Functional Medicine is an integrative medicine philosophy that uniquely incorporates 4P Medicine with a focus on function and dysfunction and the necessity to consider the physiological events that determine the balance between the two. The LIFE-HOUSE research project is designed to evaluate the impact of a personalized lifestyle intervention program on functional capacity as an approach to quantitating health, and its relationship to well understood disease risk determinants.

Individuals will be offered the opportunity to participate in all Umbrellas and Buckets for which they qualify. They may accept or reject participation in any Umbrella or Bucket and yet remain eligible for participation in the overall Tent. Due to the structure of the uniquely defined yet overlapping system of Umbrellas and Buckets, a specific Subject may participate consecutively and/or sequentially in a series of Umbrella and Buckets as applicable and their data may be included in multiple Umbrella and Bucket analyses.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •General Inclusion Criteria for 'N of 1' Tent:
  • •male or female
  • •ages 18-80, inclusive
  • •willing to give written informed consent to participate in the study

排除标准

  • •for 'M of 1' Tent:
  • •Medical History and Concurrent Diseases:
  • •A serious, unstable illness including cardiac, hepatic, renal, gastrointestinal, respiratory, endocrinologic, neurologic, immunologic/rheumatological, or hematologic disease.
  • •Known infection with HIV, TB or Hepatitis B or C.
  • •Inability to comply with study and/or follow-up visits.
  • •Any concurrent condition (including clinically significant abnormalities in medical history, physical examination or laboratory evaluations) which, in the opinion of the PI, would preclude safe participation in this study or interfere with compliance.
  • •Any sound medical, psychiatric and/or social reason which, in the opinion of the PI, would preclude safe participation in this study or interfere with compliance.
  • •The following describes specific inclusion and/or exclusion criteria applicable to individual study arms.
  • •----------------------------------------------------------
  • •Wellness Umbrella:
  • •Specific Exclusion Criteria:
  • •MOS SF-36 QN general score < 60
  • •Elevated Homocysteine Bucket:
  • •Specific Inclusion Criteria:
  • •Elevated Homocysteine Level ≥ 10.4 µmol/L
  • •Specific Exclusion Criteria:
  • •MOS SF-36 QN general score < 60
  • •Dental Health Umbrella:
  • •Specific Inclusion Criteria:
  • •Participants with extensive gingivitis/periodontitis/Caries/Painful teeth/Fractured Teeth. Identification of any of the following on physical exam: gingivitis, receding gumlines, periodontitis, fractured teeth, multiple unrestored caries. Identification on history of bleeding gums, bleeding while flossing, bleeding when brushing, chronic sores in the mouth, painful teeth, pain when biting on aluminum foil.
  • •Neurological Health Umbrella:
  • •Specific Inclusion Criteria:
  • •Elevated score on any subscale of Depression Anxiety Stress Scale (DASS) QN; and/or a score demonstrating mild or moderate depression or anxiety on Beck Depression Score and Beck Anxiety Score; and/or a MOS SF-36 subscale Emotional Role Functioning or Mental Health < 50; and/or PROMIS Cognitive Function QN score <
  • •Autoimmune and Inflammatory Conditions Umbrella:
  • •Specific Inclusion Criteria:
  • •Symptoms, signs, laboratory biomarkers or diagnosis consistent with the features/diagnosis of an Autoimmune/Inflammatory Condition (excluding metabolic disorders/atherosclerosis) and ill-defined conditions characterized by symptomatic fatigue/myalgias.
  • •Elevated ANA Bucket:
  • •Specific Inclusion Criteria:
  • •General Inclusion Criteria for Autoimmune and Inflammatory Conditions Umbrella
  • •Elevated ANA Level > 1:40 titer (A specified sub-group for analysis will be all with two baseline elevated ANA Level > 1:40 titer.)
  • •Specific Exclusion Criteria:
  • •Symptoms, signs, laboratory biomarkers (excluding ANA) or diagnosis consistent with the features/diagnosis of an Autoimmune/Inflammatory Condition (excluding metabolic disorders/atherosclerosis)
  • •Autoimmune Conditions Bucket:
  • •Specific Inclusion Criteria:
  • •Established Diagnosis of an autoimmune condition (Systemic Lupus Erythematosus, Rheumatoid Arthritis, Inflammatory Bowel Disease and Hashimoto's Thyroiditis) with ANA level >1:80 titer, rheumatoid factor (RF) ≥ 14 IU/ml, fecal calprotectin ≥ 50 mcg/g and thyroid autoantibody levels specifically thyroglobulin antibodies ≥ 115 IU/ml and/or thyroid peroxidase antibodies ≥ 35 IU/ml.
  • •Symptomatic Fatigue and Myalgia Bucket:
  • •Specific Inclusion Criteria:
  • •Two of the following five features have been generally present for at least 3 months:
  • •Widespread bodily pain (pain in 3 of 5 regions (Left upper, right upper, left lower, right lower, axial) with and without symptomatic trigger points
  • •Generalized fatigue
  • •Sleep disturbances including awakening unrefreshed
  • •Cognitive (memory or thought) problems
  • •Post-exertional malaise
  • •Gastrointestinal Health Umbrella:
  • •Specific Inclusion Criteria:
  • •Symptoms, signs, laboratory biomarkers or diagnosis consistent with the features/diagnosis of Irritable Bowel Syndrome and other GI symptomatology (excluding Inflammatory Bowel Disease) as well as physiological challenges with healthy detoxification
  • •IBS Bucket:
  • •Specific Inclusion Criteria:
  • •Symptoms, signs, laboratory biomarkers or diagnosis consistent with the features/diagnosis of Irritable Bowel Syndrome and other GI symptomatology (excluding Inflammatory Bowel Disease)
  • •Detoxification Bucket:
  • 另有 36 项未显示

研究组 & 干预措施

N of 1 Tent

Other

Personalized dietary supplements, food plans, and behavioral change support program for a broad group (both an employee population and those recruited from practitioner practices) inclusive of all study Participants and specifically generally healthy individuals, those with established disease/conditions requiring a personalized approach, those with diseases/conditions currently with low prevalence in our study population and those women currently pregnant or breastfeeding.

干预措施: Supplements and/or medical foods (Dietary Supplement)

N of 1 Tent

Other

Personalized dietary supplements, food plans, and behavioral change support program for a broad group (both an employee population and those recruited from practitioner practices) inclusive of all study Participants and specifically generally healthy individuals, those with established disease/conditions requiring a personalized approach, those with diseases/conditions currently with low prevalence in our study population and those women currently pregnant or breastfeeding.

干预措施: Behavioral change support program (Behavioral)

N of 1 Tent

Other

Personalized dietary supplements, food plans, and behavioral change support program for a broad group (both an employee population and those recruited from practitioner practices) inclusive of all study Participants and specifically generally healthy individuals, those with established disease/conditions requiring a personalized approach, those with diseases/conditions currently with low prevalence in our study population and those women currently pregnant or breastfeeding.

干预措施: Food plan (Other)

Wellness Umbrella

Other

Personalized dietary supplements, food plans, and behavioral change support program for a broad group of individuals characterized by minimal physical complaints and laboratory biomarkers of modest clinical significance.

干预措施: Supplements and/or medical foods (Dietary Supplement)

Wellness Umbrella

Other

Personalized dietary supplements, food plans, and behavioral change support program for a broad group of individuals characterized by minimal physical complaints and laboratory biomarkers of modest clinical significance.

干预措施: Behavioral change support program (Behavioral)

Wellness Umbrella

Other

Personalized dietary supplements, food plans, and behavioral change support program for a broad group of individuals characterized by minimal physical complaints and laboratory biomarkers of modest clinical significance.

干预措施: Food plan (Other)

Elevated Homocysteine Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for individuals from the Wellness Umbrella with elevated homocysteine level ≥ 10.4 µmol/L.

干预措施: Supplements and/or medical foods (Dietary Supplement)

Elevated Homocysteine Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for individuals from the Wellness Umbrella with elevated homocysteine level ≥ 10.4 µmol/L.

干预措施: Behavioral change support program (Behavioral)

Elevated Homocysteine Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for individuals from the Wellness Umbrella with elevated homocysteine level ≥ 10.4 µmol/L.

干预措施: Food plan (Other)

Dental Health Umbrella

Other

Personalized dietary supplements, food plans, and behavioral change support program for a broad group of individuals with established dental disease.

干预措施: Supplements and/or medical foods (Dietary Supplement)

Dental Health Umbrella

Other

Personalized dietary supplements, food plans, and behavioral change support program for a broad group of individuals with established dental disease.

干预措施: Behavioral change support program (Behavioral)

Dental Health Umbrella

Other

Personalized dietary supplements, food plans, and behavioral change support program for a broad group of individuals with established dental disease.

干预措施: Food plan (Other)

Immune Health Umbrella

Other

Personalized dietary supplements, food plans, and behavioral change support program for a broad group of individuals with autoimmune/inflammatory conditions (excluding metabolic disorders/atherosclerosis)

干预措施: Supplements and/or medical foods (Dietary Supplement)

Immune Health Umbrella

Other

Personalized dietary supplements, food plans, and behavioral change support program for a broad group of individuals with autoimmune/inflammatory conditions (excluding metabolic disorders/atherosclerosis)

干预措施: Behavioral change support program (Behavioral)

Immune Health Umbrella

Other

Personalized dietary supplements, food plans, and behavioral change support program for a broad group of individuals with autoimmune/inflammatory conditions (excluding metabolic disorders/atherosclerosis)

干预措施: Food plan (Other)

Elevated Anti-Nuclear Antibodies (ANA) Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of individuals with elevated levels of antinuclear antibodies (preclinical symptomatology only).

干预措施: Supplements and/or medical foods (Dietary Supplement)

Elevated Anti-Nuclear Antibodies (ANA) Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of individuals with elevated levels of antinuclear antibodies (preclinical symptomatology only).

干预措施: Behavioral change support program (Behavioral)

Elevated Anti-Nuclear Antibodies (ANA) Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of individuals with elevated levels of antinuclear antibodies (preclinical symptomatology only).

干预措施: Food plan (Other)

Autoimmune Conditions Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of individuals with an established diagnosis of an autoimmune conditions (Systemic Lupus Erythematosus, Rheumatoid Arthritis, Inflammatory Bowel Disease and Hashimoto's Thyroiditis) with ANA level >1:80 titer, rheumatoid factor (RF) ≥ 14 IU/ml, fecal calprotectin ≥ 50 mcg/g and thyroid autoantibody levels specifically thyroglobulin antibodies ≥ 115 IU/ml and/or thyroid peroxidase antibodies ≥ 35 IU/ml.

干预措施: Supplements and/or medical foods (Dietary Supplement)

Autoimmune Conditions Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of individuals with an established diagnosis of an autoimmune conditions (Systemic Lupus Erythematosus, Rheumatoid Arthritis, Inflammatory Bowel Disease and Hashimoto's Thyroiditis) with ANA level >1:80 titer, rheumatoid factor (RF) ≥ 14 IU/ml, fecal calprotectin ≥ 50 mcg/g and thyroid autoantibody levels specifically thyroglobulin antibodies ≥ 115 IU/ml and/or thyroid peroxidase antibodies ≥ 35 IU/ml.

干预措施: Behavioral change support program (Behavioral)

Autoimmune Conditions Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of individuals with an established diagnosis of an autoimmune conditions (Systemic Lupus Erythematosus, Rheumatoid Arthritis, Inflammatory Bowel Disease and Hashimoto's Thyroiditis) with ANA level >1:80 titer, rheumatoid factor (RF) ≥ 14 IU/ml, fecal calprotectin ≥ 50 mcg/g and thyroid autoantibody levels specifically thyroglobulin antibodies ≥ 115 IU/ml and/or thyroid peroxidase antibodies ≥ 35 IU/ml.

干预措施: Food plan (Other)

Symptomatic Fatigue/Myalgias Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a broad employee health group with symptoms of persistent fatigue and myalgias.

干预措施: Supplements and/or medical foods (Dietary Supplement)

Symptomatic Fatigue/Myalgias Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a broad employee health group with symptoms of persistent fatigue and myalgias.

干预措施: Behavioral change support program (Behavioral)

Symptomatic Fatigue/Myalgias Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a broad employee health group with symptoms of persistent fatigue and myalgias.

干预措施: Food plan (Other)

Wellness Detoxification Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of individuals characterized by minimal physical complaints and normal biomarkers.

干预措施: Food plan (Other)

Gastrointestinal Health Umbrella

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of individuals with conditions associated with issues of gastrointestinal health and of environmental toxicity or dysfunction related to detoxification of external toxins and internal metabolites.

干预措施: Supplements and/or medical foods (Dietary Supplement)

Gastrointestinal Health Umbrella

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of individuals with conditions associated with issues of gastrointestinal health and of environmental toxicity or dysfunction related to detoxification of external toxins and internal metabolites.

干预措施: Behavioral change support program (Behavioral)

Gastrointestinal Health Umbrella

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of individuals with conditions associated with issues of gastrointestinal health and of environmental toxicity or dysfunction related to detoxification of external toxins and internal metabolites.

干预措施: Food plan (Other)

Irritable Bowel Syndrome (IBS) Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of individuals with conditions associated with issues of gastrointestinal health.

干预措施: Supplements and/or medical foods (Dietary Supplement)

Irritable Bowel Syndrome (IBS) Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of individuals with conditions associated with issues of gastrointestinal health.

干预措施: Behavioral change support program (Behavioral)

Irritable Bowel Syndrome (IBS) Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of individuals with conditions associated with issues of gastrointestinal health.

干预措施: Food plan (Other)

Detoxification Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of individuals with conditions associated with issues of environmental toxicity or dysfunction related to detoxification of external toxins and internal metabolites.

干预措施: Supplements and/or medical foods (Dietary Supplement)

Detoxification Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of individuals with conditions associated with issues of environmental toxicity or dysfunction related to detoxification of external toxins and internal metabolites.

干预措施: Behavioral change support program (Behavioral)

Detoxification Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of individuals with conditions associated with issues of environmental toxicity or dysfunction related to detoxification of external toxins and internal metabolites.

干预措施: Food plan (Other)

Wellness Detoxification Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of individuals characterized by minimal physical complaints and normal biomarkers.

干预措施: Supplements and/or medical foods (Dietary Supplement)

Wellness Detoxification Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of individuals characterized by minimal physical complaints and normal biomarkers.

干预措施: Behavioral change support program (Behavioral)

Metabolic Health Umbrella

Other

Personalized dietary supplements, food plans, and behavioral change support program for a broad group of participants classified as desirable weight with and without markers of dysglycemia/dyslipidemia or overweight/obese with and without markers of dysglycemia/dyslipidemia).

干预措施: Supplements and/or medical foods (Dietary Supplement)

Metabolic Health Umbrella

Other

Personalized dietary supplements, food plans, and behavioral change support program for a broad group of participants classified as desirable weight with and without markers of dysglycemia/dyslipidemia or overweight/obese with and without markers of dysglycemia/dyslipidemia).

干预措施: Behavioral change support program (Behavioral)

Metabolic Health Umbrella

Other

Personalized dietary supplements, food plans, and behavioral change support program for a broad group of participants classified as desirable weight with and without markers of dysglycemia/dyslipidemia or overweight/obese with and without markers of dysglycemia/dyslipidemia).

干预措施: Food plan (Other)

Consequences of Metabolic (Dys)function Bucket C/S Design

Other

Personalized dietary supplements, food plans, and behavioral change support program for a broad group of participants classified as desirable weight with and without markers of dysglycemia/dyslipidemia or overweight/obese with and without markers of dysglycemia/dyslipidemia). C/S = crossover

干预措施: Supplements and/or medical foods (Dietary Supplement)

Consequences of Metabolic (Dys)function Bucket C/S Design

Other

Personalized dietary supplements, food plans, and behavioral change support program for a broad group of participants classified as desirable weight with and without markers of dysglycemia/dyslipidemia or overweight/obese with and without markers of dysglycemia/dyslipidemia). C/S = crossover

干预措施: Behavioral change support program (Behavioral)

Consequences of Metabolic (Dys)function Bucket C/S Design

Other

Personalized dietary supplements, food plans, and behavioral change support program for a broad group of participants classified as desirable weight with and without markers of dysglycemia/dyslipidemia or overweight/obese with and without markers of dysglycemia/dyslipidemia). C/S = crossover

干预措施: Food plan (Other)

Consequences of Metabolic (Dys)function Bucket R/I Design

Other

Personalized dietary supplements, food plans, and behavioral change support program for a broad group of participants classified as desirable weight with markers of dysglycemia/dyslipidemia or overweight/obese with and without markers of dysglycemia/dyslipidemia). R/I = randomization/inclusion

干预措施: Supplements and/or medical foods (Dietary Supplement)

Consequences of Metabolic (Dys)function Bucket R/I Design

Other

Personalized dietary supplements, food plans, and behavioral change support program for a broad group of participants classified as desirable weight with markers of dysglycemia/dyslipidemia or overweight/obese with and without markers of dysglycemia/dyslipidemia). R/I = randomization/inclusion

干预措施: Behavioral change support program (Behavioral)

Consequences of Metabolic (Dys)function Bucket R/I Design

Other

Personalized dietary supplements, food plans, and behavioral change support program for a broad group of participants classified as desirable weight with markers of dysglycemia/dyslipidemia or overweight/obese with and without markers of dysglycemia/dyslipidemia). R/I = randomization/inclusion

干预措施: Food plan (Other)

Ketogenic Product Development Exploratory Group

Other

Subgroup investigation in participants (classified as desirable weight with and without markers of dysglycemia/dyslipidemia or overweight/obese with and without markers of dysglycemia/dyslipidemia) during their 8- or 12-week ketogenic program intervention phase

干预措施: Supplements and/or medical foods (Dietary Supplement)

Ketogenic Product Development Exploratory Group

Other

Subgroup investigation in participants (classified as desirable weight with and without markers of dysglycemia/dyslipidemia or overweight/obese with and without markers of dysglycemia/dyslipidemia) during their 8- or 12-week ketogenic program intervention phase

干预措施: Behavioral change support program (Behavioral)

Ketogenic Product Development Exploratory Group

Other

Subgroup investigation in participants (classified as desirable weight with and without markers of dysglycemia/dyslipidemia or overweight/obese with and without markers of dysglycemia/dyslipidemia) during their 8- or 12-week ketogenic program intervention phase

干预措施: Food plan (Other)

Reproductive Health Umbrella

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of participants with conditions associated with reproductive and hormonal health (including polycystic ovary syndrome, premenstrual syndrome, endometriosis, peri-menopause and menopausal conditions, women currently pregnant or breastfeeding, testosterone deficiency and andropause/late onset hypogonadism, and prostate health).

干预措施: Supplements and/or medical foods (Dietary Supplement)

Reproductive Health Umbrella

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of participants with conditions associated with reproductive and hormonal health (including polycystic ovary syndrome, premenstrual syndrome, endometriosis, peri-menopause and menopausal conditions, women currently pregnant or breastfeeding, testosterone deficiency and andropause/late onset hypogonadism, and prostate health).

干预措施: Behavioral change support program (Behavioral)

Reproductive Health Umbrella

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of participants with conditions associated with reproductive and hormonal health (including polycystic ovary syndrome, premenstrual syndrome, endometriosis, peri-menopause and menopausal conditions, women currently pregnant or breastfeeding, testosterone deficiency and andropause/late onset hypogonadism, and prostate health).

干预措施: Food plan (Other)

Perimenopausal and Menopausal Transitions Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of women with conditions associated with reproductive and hormonal health specifically peri-menopause and menopausal conditions.

干预措施: Supplements and/or medical foods (Dietary Supplement)

Perimenopausal and Menopausal Transitions Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of women with conditions associated with reproductive and hormonal health specifically peri-menopause and menopausal conditions.

干预措施: Behavioral change support program (Behavioral)

Perimenopausal and Menopausal Transitions Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of women with conditions associated with reproductive and hormonal health specifically peri-menopause and menopausal conditions.

干预措施: Food plan (Other)

Premenstrual Syndrome Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of women with conditions associated with reproductive and hormonal health specifically premenstrual syndrome.

干预措施: Supplements and/or medical foods (Dietary Supplement)

Premenstrual Syndrome Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of women with conditions associated with reproductive and hormonal health specifically premenstrual syndrome.

干预措施: Behavioral change support program (Behavioral)

Premenstrual Syndrome Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of women with conditions associated with reproductive and hormonal health specifically premenstrual syndrome.

干预措施: Food plan (Other)

Polycystic Ovary Syndrome (PCOS) Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of women with PCOS with signs/symptoms/biomarkers of both metabolic dysfunction and hormonal derangements.

干预措施: Supplements and/or medical foods (Dietary Supplement)

Polycystic Ovary Syndrome (PCOS) Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of women with PCOS with signs/symptoms/biomarkers of both metabolic dysfunction and hormonal derangements.

干预措施: Behavioral change support program (Behavioral)

Polycystic Ovary Syndrome (PCOS) Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of women with PCOS with signs/symptoms/biomarkers of both metabolic dysfunction and hormonal derangements.

干预措施: Food plan (Other)

Andropause/Late Onset Hypogonadism Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of men with conditions associated with reproductive and hormonal health specifically testosterone deficiency and andropause/late onset hypogonadism.

干预措施: Supplements and/or medical foods (Dietary Supplement)

Andropause/Late Onset Hypogonadism Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of men with conditions associated with reproductive and hormonal health specifically testosterone deficiency and andropause/late onset hypogonadism.

干预措施: Behavioral change support program (Behavioral)

Andropause/Late Onset Hypogonadism Bucket

Other

Personalized dietary supplements, food plans, and behavioral change support program for a group of men with conditions associated with reproductive and hormonal health specifically testosterone deficiency and andropause/late onset hypogonadism.

干预措施: Food plan (Other)

结局指标

主要结局

University of Rhode Island Change Assessment (URICA) questionnaire

时间窗: Change from baseline at 12 months

URICA questionnaire is a 32 item self-report measure that includes 4 subscales measuring the stages of change: Precontemplation, Contemplation, Action, and Maintenance (there is also a 24 item version). Responses are given on a 5 point Likert scale ranging from (1=strong disagreement to 5=strong agreement),

Depression Anxiety, Stress Scale (DASS) questionnaire

时间窗: Change from baseline at 12 months

The Depression, Anxiety and Stress Scale is a 21 items questionnaire that includes a set of three self-report scales designed to measure the emotional states of depression, anxiety and stress. Outcome is divided into normal, mild, moderate, severe, and very severe for each of the 3 categories: Depression, Anxiety, and Stress. A low score represents the normal and the higher the score the more severe the outcome.

Medical Outcomes Study Short Form 36 (MOS SF-36) questionnaire

时间窗: Change from baseline at 12 months

The MOS SF-36 is an indicator of overall health status. It has an eight scaled scores; the scores are weighted sums of the questions in each section. Scores range from 0 - 100 Lower scores = more disability, higher scores = less disability.

次要结局

  • Waist Circumference (WC)(Change from baseline at 12 months)
  • Weight(Change from baseline at12 months)
  • Glucose(Change from baseline at 12 months)
  • High sensitivity C-Reactive Protein (Hs-CRP)(Change from baseline at 12 months)
  • Omega-3 Fatty Acids(Change from baseline at 12 months)
  • Waist to Hip Ratio (WHR)(Change from baseline at 12 months)
  • Homocysteine(Change from baseline at 12 months)
  • Body Mass Index (BMI)(Change from baseline at 12 months)
  • Height(Change from baseline at 12 months)
  • Hip Circumference (HC)(Change from baseline at12 months)
  • Total Cholesterol(Change from baseline at 12 months)
  • 25-hydroxy (OH) Vitamin D3(Change from baseline at 12 months)
  • Anti-Nuclear Antibodies (ANA)(Change from baseline at 12 months)
  • Beck Depression Inventory (BDI)(Change from baseline at 12 months)
  • Beck Anxiety Inventory (BAI)(Change from baseline at12 months)
  • Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance Test(Change from baseline at 12 months)
  • Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety Test(Change from baseline at12 months)
  • Patient-Reported Outcomes Measurement Information System (PROMIS) Depression Short Form (SF)(Change from baseline at 12 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验